OptiCept Technologies (OPTI) Q3 2024 earnings summary

Executive summary

• Achieved significant commercial breakthroughs in Q3, including new agreements in olive oil, wine, and juice industries, and a collaboration with Saab for expansion in Thailand.

• Transitioned from R&D to a commercial phase, with global launch of the PEF S7 system for solid foods and increased focus on sales and marketing.

• Announced a rights issue of approximately SEK 80.4 million to support continued growth and commercialization.

• Installed first new solid foods system at Steinicke in Germany and expanded presence in Asia with an innovation center in China.

• Secured a breakthrough order in Central America with MexiFrutas, a leading juice producer.

Financial highlights

• Q3 net revenue increased to SEK 4,119 thousand from SEK 1,149 thousand year-over-year; net sales were SEK 3,883 thousand.

• Operating income for Q3 was SEK -12,471 thousand, an improvement from SEK -17,768 thousand in Q3 2023.

• EBITDA for Q3 was SEK -9,944 thousand, up from SEK -12,749 thousand in Q3 2023.

• Net loss for Q3 was SEK -13,150 thousand, compared to SEK -20,845 thousand in Q3 2023.

• Cash and cash equivalents at period end were SEK 4,559 thousand, down from SEK 12,185 thousand a year earlier.

Outlook and guidance

• Management expects positive cash flow in 2024 based on projected sales and cost controls, supported by the announced rights issue.

• Financing from the rights issue is expected to provide liquidity into Q4 2025, enabling uninterrupted commercialization and project completion.

• Continued focus on global commercialization, with new product launches and expansion in key markets such as Europe, Asia, and Central America.